News

New evidence reveals streptococcus anginosus drives gastric cancer development

ASCO GI 2026: Zanidatamab and chemotherapy can slow cancer growth, extend survival in some people with gastroesophageal adenocarcinoma

Supramolecular self-assembly with dual functions of GSH-synthesis inhibition and consumption for efficient chemodynamic therapy

When ovarian cancer alters the abdominal cavity

Inhalable therapy aims for one-two punch against advanced melanoma

ASCO GI 2026: Combining encorafenib and cetuximab with FOLFIRI may be effective first-line treatment for advanced CRC

ASCO GI 2026: ‘triple-punch’ combo therapy slows progressions of some metastatic colorectal cancers

ASCO GI 2026: Long-term study suggests walking is key to managing cancer-related fatigue

New cervical cancer screening guidelines from the US Department of Health and Human Services

ASCO GI 2026: GLP-1 receptor agonists (GLP-1s) may help reduce the risk of developing colorectal cancer

A nuclear target to revive anti-tumour immunity

Injectable breast ‘implant’ offers alternative to traditional surgeries